Café

© 2026 Longbridge｜Terms of Service Privacy Policy

LUYE PHARMA

02186

2.0203.81% ( -0.080 )

Delay Closed: Jul 30, 16:08:22

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

The Hong Kong Misfit Toys: From Solid Cash Cows to Epic Frauds
Global Report·8 hours ago
09890-0.79%03311+1.75%
Luye Pharma Group (LYPHF) Receives a Buy from Essence Securities
Tip Ranks·Jul 24 at 12:05 AM
02186-3.81%
Inside the HK Mid-Cap Shakeup: Wenge's AI Push and Luye Pharma's Pipeline Catalysts
Global Report·Jul 21 at 04:12 AM
01157-0.52%02186-3.81%
The Hong Kong Orphans: AI Hype, Biotech Survival, and a Tea Performance
Global Report·Jul 17 at 04:12 AM
02186-3.81%05593
Luye Pharma shareholders back share issuance mandate at AGM poll
PUBT·Jun 26 at 08:01 AM
02186-3.81%
Luye Pharma Surges On Positive Clinical Trial Results for LY03015
HK Stock Market Update·Jun 17 at 12:21 AM
02186-3.81%
Greentown Pharma Jumps Over 8% on Positive Clinical Results for Tardive Dyskinesia Drug
HK Stock Market Update·Jun 17 at 12:15 AM
02186-3.81%
Luye Pharma Surges 8% After Clinical Positive Results for TD Drug
HK Stock Market Update·Jun 16 at 09:44 PM
02186-3.81%
Luye Pharma Surges on Successful VMAT2/Sigma-1R Trial Results
HK Stock Market Update·Jun 16 at 09:39 PM
02186-3.81%
Luye Pharma Surges 8% as LY03015 Phase II Trial Hits Endpoint
HK Stock Market Update·Jun 16 at 09:27 PM
02186-3.81%
Luye Pharma’s Novel CNS Drug LY03015 Delivers Strong Phase 2 Data in Tardive Dyskinesia
Tip Ranks·Jun 16 at 09:41 AM
02186-3.81%
Luye Pharma Raises US$180 Million via Premium-Priced 2031 Convertible Bonds
Tip Ranks·Jun 10 at 07:07 PM
02186-3.81%
Top 10 HK Stock Losers (6.4)
Top Gainers&Losers·Jun 4 at 03:30 AM
00290+11.18%01879-6.72%
LUYE PHARMA Issues USD180M CBs at 24.9% Premium, Plans Concurrent Repurchase of 2028 CBs
AASTOCKS News·Jun 3 at 08:25 PM
02186-3.81%